Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer

作者:Crowley Vincent M; Huard Dustin J E; Lieberman Raquel L; Blagg Brian S J*
来源:Chemistry - A European Journal, 2017, 23(62): 15775-15782.
DOI:10.1002/chem.201703398

摘要

Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum (ER) resident isoform of the 90kDa heat shock protein (Hsp90) family and its inhibition represents a promising therapeutic target for the treatment of many diseases. Modification of the first generation cis-amide bioisostere imidazole to alter the angle between the resorcinol ring and the benzyl side chain via cis-amide replacements produced compounds with improved Grp94 affinity and selectivity. Structure-activity relationship studies led to the discovery of compound 30, which exhibits 540nm affinity and 73-fold selectivity towards Grp94. Grp94 is responsible for the maturation and trafficking of proteins associated with cell signaling and motility, including select integrins. The Grp94-selective inhibitor 30 was shown to exhibit potent anti-migratory effects against multiple aggressive and metastatic cancers.

  • 出版日期2017-11-7